Boston Herald's Ross reports Mitt Romney owns stock in 2 companies involved in embryonic stem cell research, biomedical firms Novo Nordisk and Millipore corp, "both of which use human embryos to research cures for chronic diseases." In his "public actions," Romney has "occupied a middle ground on stem cell research," supporting "using excess embryos created at fertility clinics, but he has opposed cloning or creating new embryos solely for experimentation."
Romney's "assets are held in a blind trust created after he was elected" Gov in '02. The manager of his trust, Brad Malt of the firm Ropes & Gray, "said Romney had no way of knowing how his funds were invested." While many candidates sell stocks held in blind trust, Romney didn't do so before WH '08. "Candidates can also set restrictions on their investments when a blind trust is created, but Malt said Romney did not take that step in 2002."
Romney's financial statement shows he owns between $100K and $250K in Novo Nordisk, "a Denmark-based company engaged in research projects involving embryonic stem cells" (8/15).
Romney has claimed that his election year conversion to the pro-life cause is a result of studying embryonic stem cells, and how his opposition to embryonic stems cell research was the catalyst for his pro-life conversion.